✦ LIBER ✦

Orally Active Peptidic Bradykinin B1 Receptor Antagonists Engineered from a Cyclotide Scaffold for Inflammatory Pain Treatment

✍ Scribed by Clarence T. T. Wong; Dr. Dewi K. Rowlands; Dr. Chi-Hang Wong; Dr. Theodore W. C. Lo; Giang K. T. Nguyen; Prof. Hoi-Yeung Li; Prof. James P. Tam

Book ID: 111900731
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 109 KB
Volume: 51
Category: Article
ISSN: 0044-8249
DOI: 10.1002/anie.201200984

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: 1-(2-Nitrophenyl)th

ChemInform Abstract: 1-(2-Nitrophenyl)thiosemicarbazides: A Novel Class of Potent, Orally Active Non-Peptide Antagonists for the Bradykinin B2 Receptor.

✍ Edward K. Dziadulewicz; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB 👁 1 views

Pharmacological Characterization of MK-0

Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

✍ Salvatore, C. A.; Hershey, J. C.; Corcoran, H. A.; Fay, J. F.; Johnston, V. K.; 📂 Article 📅 2007 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 370 KB